1. Home
  2. AZN
  3. AZN News

Latest AstraZeneca PLC (AZN) News on September 13, 2025

IonQ Secures Regulatory Approval from the UK Investment Security Unit (ISU) for the Acquisition of Oxford Ionics
AZN

Business Wire

15 hours ago

IonQ Secures Regulatory Approval from the UK Investment Security Unit (ISU) for the Acquisition of Oxford Ionics

The Zacks Analyst Blog Highlights Oracle, AstraZeneca, Shopify and Blue Ridge Bankshares
AZN

Zacks

18 hours ago

The Zacks Analyst Blog Highlights Oracle, AstraZeneca, Shopify and Blue Ridge Bankshares

UK's September 2025 Stock Selections Estimated Below Intrinsic Value
AZN

Simply Wall St.

19 hours ago

UK's September 2025 Stock Selections Estimated Below Intrinsic Value

AstraZeneca (AZN) Price Target Backed by Goldman After Baxdrostat Phase 3 Data
AZN

Insider Monkey

21 hours ago

AstraZeneca (AZN) Price Target Backed by Goldman After Baxdrostat Phase 3 Data

Top Research Reports for Oracle, AstraZeneca & Shopify
AZN

Zacks

a day ago

Top Research Reports for Oracle, AstraZeneca & Shopify

TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
AZN

Zacks

2 days ago

TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape

YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC
AZN

PR Newswire

2 days ago

YolTech Therapeutics Raises $45 Million in Series B Financing Led by AstraZeneca-CICC

China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington
AZN

The Daily Upside

2 days ago

China’s Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington

Britain defends investment record as Merck scraps labs over pharma environment
AZN

Reuters

2 days ago

Britain defends investment record as Merck scraps labs over pharma environment

UK Value Stocks Trading At Estimated Discounts For September 2025
AZN

Simply Wall St.

2 days ago

UK Value Stocks Trading At Estimated Discounts For September 2025

ENHERTU® Type II Variation Application Validated in the EU for Previously Treated Patients with HER2 Positive Metastatic Solid Tumors
AZN

Business Wire

2 days ago

ENHERTU® Type II Variation Application Validated in the EU for Previously Treated Patients with HER2 Positive Metastatic Solid Tumors

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order
AZN

Investor's Business Daily

2 days ago

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order

FDA Expands Approval For AstraZeneca's Drug For Pediatric Patients With Rare Type Of Cancer
AZN

Benzinga

2 days ago

FDA Expands Approval For AstraZeneca's Drug For Pediatric Patients With Rare Type Of Cancer

Will big investment promises bring back US manufacturing?
AZN

Manufacturing Dive

2 days ago

Will big investment promises bring back US manufacturing?

AZN

MT Newswires

2 days ago

Astrazeneca Receives FDA Approval for Selumetinib for Pediatric Patients With Neurofibromatosis Type 1

3 UK Stocks That May Be Priced Below Their Intrinsic Value Estimates
AZN

Simply Wall St.

3 days ago

3 UK Stocks That May Be Priced Below Their Intrinsic Value Estimates

BizClik Unveils the 250 Companies Driving Sustainability in 2025
AZN

GlobeNewswire

3 days ago

BizClik Unveils the 250 Companies Driving Sustainability in 2025

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
AZN

Zacks

4 days ago

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program
AZN

GlobeNewswire

4 days ago

Tive Partners with AstraZeneca to Provide a Temperature Tracker for FluMist Home Delivery Program

BizClik Announces the Top 250 Companies in Sustainability for 2025
AZN

PR Newswire

4 days ago

BizClik Announces the Top 250 Companies in Sustainability for 2025

Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
AZN

Zacks

4 days ago

Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
AZN

Investor's Business Daily

4 days ago

Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study
AZN

Benzinga

4 days ago

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

AZN

Medical Device Network

5 days ago

Roche receives CE IVDR approval for Ventana label expansions

AstraZeneca’s Tagrisso combination shows survival benefit in lung cancer trial
AZN

Clinical Trials Arena

5 days ago

AstraZeneca’s Tagrisso combination shows survival benefit in lung cancer trial

AZN

MT Newswires

5 days ago

AstraZeneca Says Tagrisso Combination Therapy Demonstrates Superior Overall Survival in Late-Stage Trial

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts
AZN

Motley Fool

6 days ago

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts

TAGRISSO® (osimertinib) plus chemotherapy demonstrated a median overall survival of nearly four years, the longest benefit ever reported in a global Phase III trial in EGFR-mutated advanced lung cancer
AZN

Business Wire

6 days ago

TAGRISSO® (osimertinib) plus chemotherapy demonstrated a median overall survival of nearly four years, the longest benefit ever reported in a global Phase III trial in EGFR-mutated advanced lung cancer

AstraZeneca's (LON:AZN) investors will be pleased with their notable 61% return over the last five years
AZN

Simply Wall St.

7 days ago

AstraZeneca's (LON:AZN) investors will be pleased with their notable 61% return over the last five years

Goldman Sachs Remains Bullish on AstraZeneca (AZN)
AZN

Insider Monkey

7 days ago

Goldman Sachs Remains Bullish on AstraZeneca (AZN)

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
AZN

GlobeNewswire

8 days ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025

Ibex Medical Analytics Announces IVDR Certification for HER2 Biomarker Scoring Solution in Breast Cancer
AZN

Business Wire

8 days ago

Ibex Medical Analytics Announces IVDR Certification for HER2 Biomarker Scoring Solution in Breast Cancer

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing
AZN

Business Wire

9 days ago

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

Mineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh Peak
AZN

Insider Monkey

9 days ago

Mineralys (MLYS) Steals Spotlight From AstraZeneca, Reaches Fresh Peak

Lung Disease Breakthrough Boosts United Therapeutics — and its Rivals
AZN

The Daily Upside

10 days ago

Lung Disease Breakthrough Boosts United Therapeutics — and its Rivals

AZN

Morningstar Research

10 days ago

Analyst Report: Ionis Pharmaceuticals, Inc.

More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off.
AZN

Barrons.com

10 days ago

More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off.

AstraZeneca's Latest Drug Offers Hope For Millions Battling Hard-To-Control Blood Pressure
AZN

Benzinga

11 days ago

AstraZeneca's Latest Drug Offers Hope For Millions Battling Hard-To-Control Blood Pressure

AZN

MT Newswires

11 days ago

FibroGen Completes Sale of Chinese Subsidiary to AstraZeneca

FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million
AZN

GlobeNewswire

11 days ago

FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million

ESC 2025: DAPA ACT HF-TIMI 68 trial shows promise for Dapagliflozin in acute HF
AZN

Clinical Trials Arena

12 days ago

ESC 2025: DAPA ACT HF-TIMI 68 trial shows promise for Dapagliflozin in acute HF

AstraZeneca’s baxdrostat shows promise in Phase III hypertension trial
AZN

Clinical Trials Arena

12 days ago

AstraZeneca’s baxdrostat shows promise in Phase III hypertension trial

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III ​trial
AZN

Business Wire

13 days ago

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III ​trial

AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results
AZN

Investor's Business Daily

13 days ago

AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results

Baxdrostat Phase III success at ESC accelerates RH market shift
AZN

Clinical Trials Arena

14 days ago

Baxdrostat Phase III success at ESC accelerates RH market shift

The Bull Case For Legend Biotech (LEGN) Could Change Following Appointment of CFO With Global Pharma Expertise
AZN

Simply Wall St.

14 days ago

The Bull Case For Legend Biotech (LEGN) Could Change Following Appointment of CFO With Global Pharma Expertise

AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025
AZN

Insider Monkey

16 days ago

AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025

Regeneron tees up myasthenia gravis drug approval after Phase III victory
AZN

Clinical Trials Arena

16 days ago

Regeneron tees up myasthenia gravis drug approval after Phase III victory

Box to Present at Investor Conference
AZN

Business Wire

17 days ago

Box to Present at Investor Conference

HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries
AZN

GlobeNewswire

17 days ago

HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic
AZN

GlobeNewswire

17 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma
AZN

GlobeNewswire

17 days ago

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More
AZN

GlobeNewswire

17 days ago

Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030
AZN

GlobeNewswire

18 days ago

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
AZN

GlobeNewswire

19 days ago

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China
AZN

Pharmaceutical Technology

19 days ago

Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China

AZN

Simply Wall St.

21 days ago

AstraZeneca (LSE:AZN) Joins Forces To Launch Sovereign AI Supercomputer With Sferical AI

AZN

Reuters

22 days ago

Sweden's Wallenberg groups launch joint AI company

ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment
AZN

Exec Edge

22 days ago

ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment

AZN

Morningstar Research

22 days ago

Analyst Report: Ionis Pharmaceuticals, Inc.

Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu Vaccine
AZN

Business Wire

22 days ago

Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu Vaccine

J&J to invest $2 billion to boost US manufacturing as drug tariffs loom
AZN

Reuters

23 days ago

J&J to invest $2 billion to boost US manufacturing as drug tariffs loom

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
AZN

Zacks

24 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

The Quantum Computing Race Is On: These 2 Stocks Appear Poised to Lead
AZN

Barchart

24 days ago

The Quantum Computing Race Is On: These 2 Stocks Appear Poised to Lead

AlzeCure Appoints Cecilia Wadell as New Head of Development
AZN

ACCESS Newswire

24 days ago

AlzeCure Appoints Cecilia Wadell as New Head of Development

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
AZN

Zacks

25 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Strategic Partnerships Power Tempus AI's Healthcare Expansion
AZN

Zacks

25 days ago

Strategic Partnerships Power Tempus AI's Healthcare Expansion

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
AZN

PR Newswire

25 days ago

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market
AZN

GlobeNewswire

a month ago

Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
AZN

Zacks

a month ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

AZN

MT Newswires

a month ago

Legend Biotech Names Carlos Santos CFO

AZN

MT Newswires

a month ago

FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval

AZN

MT Newswires

a month ago

FibroGen Receives Chinese Regulator's Approval for Sale of Subsidiary to AstraZeneca

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation
AZN

GlobeNewswire

a month ago

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

The Zacks Analyst Blog Highlights D-Wave Quantum, Rigetti Computing, IonQ, AstraZeneca, AWS and NVIDIA
AZN

Zacks

a month ago

The Zacks Analyst Blog Highlights D-Wave Quantum, Rigetti Computing, IonQ, AstraZeneca, AWS and NVIDIA

AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination
AZN

Simply Wall St.

a month ago

AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination

America’s first needle-free, at-home flu vaccine is now available
AZN

FastCompany

a month ago

America’s first needle-free, at-home flu vaccine is now available

Quantum Stocks Q2 2025: Are D-Wave, IonQ & Rigetti Funding the Future?
AZN

Zacks

a month ago

Quantum Stocks Q2 2025: Are D-Wave, IonQ & Rigetti Funding the Future?

AZN

MT Newswires

a month ago

European Equities Close Mixed in Friday Trading; Swiss GDP Flat in Q2

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
AZN

Zacks

a month ago

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
AZN

GlobeNewswire

a month ago

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AZN

MT Newswires

a month ago

AstraZeneca Launches At-Home Delivery Service for Nasal Spray Flu Vaccine

FLUMIST (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery
AZN

Business Wire

a month ago

FLUMIST (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth
AZN

GlobeNewswire

a month ago

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact
AZN

PR Newswire

a month ago

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact

Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors
AZN

Business Wire

a month ago

Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors

AZN

MT Newswires

a month ago

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana
AZN

Insider Monkey

a month ago

Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update
AZN

GlobeNewswire

a month ago

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?
AZN

Zacks

a month ago

IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?

Stuttering Market Research Report 2025-2035 | AstraZeneca, via Alexion, Leads with Strensiq as the First Approved Enzyme Replacement Therapy
AZN

GlobeNewswire

a month ago

Stuttering Market Research Report 2025-2035 | AstraZeneca, via Alexion, Leads with Strensiq as the First Approved Enzyme Replacement Therapy

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations
AZN

GlobeNewswire

a month ago

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

LegalZoom (LZ) Climbs to New High as Firm Raises Growth Forecast, Analyst Turns Bullish
AZN

Insider Monkey

a month ago

LegalZoom (LZ) Climbs to New High as Firm Raises Growth Forecast, Analyst Turns Bullish

Heartflow (HTFL) Soars 66% on IPO on Strong Investor Confidence
AZN

Insider Monkey

a month ago

Heartflow (HTFL) Soars 66% on IPO on Strong Investor Confidence

Varex Imaging Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
AZN

Simply Wall St.

a month ago

Varex Imaging Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Energy Fuels Inc. (TSE:EFR) Just Reported And Analysts Have Been Lifting Their Price Targets
AZN

Simply Wall St.

a month ago

Energy Fuels Inc. (TSE:EFR) Just Reported And Analysts Have Been Lifting Their Price Targets

Block Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
AZN

Simply Wall St.

a month ago

Block Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Acorn Energy Second Quarter 2025 Earnings: EPS: US$0.29 (vs US$0.11 in 2Q 2024)
AZN

Simply Wall St.

a month ago

Acorn Energy Second Quarter 2025 Earnings: EPS: US$0.29 (vs US$0.11 in 2Q 2024)

Artivion Second Quarter 2025 Earnings: Beats Expectations
AZN

Simply Wall St.

a month ago

Artivion Second Quarter 2025 Earnings: Beats Expectations

Is TransAct Technologies Incorporated (NASDAQ:TACT) Potentially Undervalued?
AZN

Simply Wall St.

a month ago

Is TransAct Technologies Incorporated (NASDAQ:TACT) Potentially Undervalued?

Share on Social Networks: